Journal Guide

Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management; and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.

Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.

Cardiovascular Toxicology is the only journal dedicated to publishing contemporary issues, timely reviews, and experimental and clinical data on the molecular therapy of cardiovascular disease. CT publishes papers that will elucidate the effects, molecular mechanisms, and signaling pathways of environmental toxicants on the cardiovascular system. Also covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. In addition, Cardiovascular Toxicology reports safety and toxicological data on new cardiovascular and non-cardiovascular drugs. This is a unique journal in which these data can be scrutinized separately from efficacy.

Cardiovascular Ultrasound is ready to receive manuscripts on all aspects of ultrasound in cardiovascular physiology and disease.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cartilage (CART) is a peer-reviewed quarterly journal on the musculoskeletal system with particular attention to cartilage repair, development, function, degeneration, transplantation, and rehabilitation. Aimed at researchers and clinicians involved in cartilage biology and repair, CART publishes full length original manuscripts on all types of cartilage including articular, nasal, auricular, tracheal/bronchial, and intervertebral disc fibrocartilage.

Case Reports in Dermatology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of dermatology, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivorship issues. The journal will also accept case reports related to the use of novel technologies, both in the area of diagnosis and treatment. Supplementary material is welcomed and free of charge. In this forum, clinicians and researchers communicate their observations to the broadest possible audience in the community.

Case Reports in Gastroenterology is a peer-reviewed, open-access journal that publishes original case reports covering the entire spectrum of gastroenterology. The journal will also accept case reports related to the use of novel technologies, both in the area of diagnosis and treatment. Supplementary material is welcomed and free of charge. The reports are organized according to the classification used by the American Gastroenterological Association Institute; it will be possible to search across the entire growing collection of case reports with universally used terms, further facilitating the retrieval of specific information. In this forum, clinicians and researchers communicate their observations to the broadest possible audience in the community.

Case Reports in Neurology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of neurology. In addition to single case studies, the journal accepts papers discussing case series, small clinical trials, and investigator-initiated trials to address the range of clinical practice. In this forum, clinicians and researchers can communicate their findings to a broader neurology community. The authors may also provide supplementary material free of charge.

Case Reports in Oncology is a peer-reviewed, open-access journal that publishes original case studies covering the entire spectrum of oncology, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivorship issues. The journal will also accept case reports dealing with the use of novel technologies, both in the area of diagnosis and treatment. In this forum, clinicians and researchers can communicate their findings to a broader oncology community. The authors may also provide supplementary material free of charge.